Zhejiang, China

Huiyan Gao

This inventor holds 1 USPTO granted patent. Top assignees: Alfred E. Tiefenbacher Gmbh & Co. Kg, Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huiyan Gao. Retrieved from https://idiyas.com/inventor/huiyan-gao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Huiyan Gao: Innovator in Pharmaceutical Granulation**

Introduction

Huiyan Gao is an accomplished inventor based in Zhejiang, China, known for his significant contributions to the pharmaceutical industry. With a focus on innovative formulations, he has developed a patent that enhances the stability and efficacy of medications.

Latest Patents

Gao holds a patent for "Candesartan cilexetil-containing granules," which include a sugar alcohol and a binder, produced through granulation with an alcoholic granulating liquid. These specialized granules are designed for tablet production, ensuring that the candesartan cilexetil is stabilized against decomposition, thereby improving the delivery and effectiveness of the medication.

Career Highlights

He has worked with reputable companies including Zhejiang Huahai Pharmaceutical Co., Ltd. and Alfred E. Tiefenbacher GmbH & Co. KG, where he has applied his expertise in pharmaceutical development. His work focuses on enhancing drug formulations, resulting in improved patient outcomes.

Collaborations

Throughout his career, Huiyan Gao has collaborated with talented colleagues such as Qiaomei Wu and Hao Chen. These partnerships have enabled him to tackle complex challenges and drive innovation in pharmaceutical formulation.

Conclusion

Huiyan Gao's innovations in the pharmaceutical field, particularly his work on stable medication formulations, have made a notable impact. As the industry continues to evolve, his contributions to granulation and drug stability remain essential to advancing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…